Confidently diagnose respiratory disease during telehealth consultations

ResAppDx is Australia's only TGA approved, clinically validated remote respiratory cough test. Developed by ResApp Health, ResAppDx analyses cough sounds using clinically validated algorithms to provide indications for lower respiratory tract disease, pneumonia, asthma/reactive airway disease exacerbations, COPD exacerbations, bronchiolitis and croup.

Clinically validated
Remote respiratory symptom testing
Instant results

Benefits for your practice

An improved telehealth assessment using ResAppDx may:

Reduce unnecessary clinic referrals and lengthy clinical testing

Facilitate earlier and better targeted treatment

Reduce the spread of infectious disease with less physical contact

Improve patient convenience and experience

How ResAppDx works

Our partners

We have partnered with these leading telehealth platforms

Please contact us if you'd like to use ResAppDx on another telehealth platform or in your clinic.

Frequently asked questions

ResAppDx can assist clinicians in the diagnosis of lower respiratory tract disease, pneumonia, asthma/reactive airway disease exacerbations, COPD exacerbations, croup and bronchiolitis (2 years and younger).

Patients who are aged 29 days or older.

If the patient is experiencing shortness of breath, difficulty breathing, sore throat, runny nose or fever it is recommended that they take the cough test. If they are not coughing spontaneously, they will need to produce involuntary coughs so that the app can capture the sounds from their lower airways.

ResAppDx is available on the Coviu and Phenix Health telehealth platforms. Contact us to learn about other options for accessing ResAppDx.

When using a telehealth platform the results will be accessible only through your login. The results are not available to the patient directly.

No. The ResAppDx Analysis Report is only made available to the clinician conducting the telehealth consultation

The performance of ResAppDx is provided in the Instructions for Use. Our clinical evidence provides information and links to download a number of peer-reviewed journal articles and conference abstracts which describe the results of our clinical studies.

Contact us to learn more

If you have any questions or would like to find out how you can use ResAppDx in your clinic, please complete the form below.

Only indicated for use on patients aged 29 days and older. The result of the test should not be used as a sole diagnosis. The result should be used as part of an overall clinical assessment of the patient. Please refer to the Instructions for Use for information on interpreting the results and the clinical performance of ResAppDx.

Copyright © 2020 ResApp Health Limited / Privacy Policy